# AngioDynamics, Inc. (ANGO)

> AngioDynamics, Inc. (ANGO) trades at $11.99 (-2.91%) as of 7:30:01 PM EDT on Oct 30, 2026, -20.70% over the past month. Market cap is $504.23M, with 1.5 days to cover in short interest.

Canonical: https://massive.com/quote/ango
Data as of: 2026-10-30T23:30:01.883Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$11.99** -0.36 (-2.91%)
As of 7:30:01 PM EDT on Oct 30, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How AngioDynamics, Inc. (ANGO) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -2.91% |
| 1W | -3.03% |
| 1M | -20.70% |
| YTD | -6.62% |
| 1Y | +1.35% |
| 52-wk range | $9.39 – $16.29 |

From daily closes through Oct 30, 2026.

## Key statistics

Today's trading snapshot for ANGO: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $11.89 – $12.34 |
| Open | $12.32 |
| Prev close | $12.35 |
| Volume | 475.83K |
| Market cap | $504.23M |
| Shares out | 42.05M |

## Valuation and profitability ratios

Valuation and profitability ratios for AngioDynamics, Inc.: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 1.55 |
| P/B | 3.08 |
| P/FCF | — |
| ROE | -20.1% |
| ROA | -13.6% |
| Debt/Equity | 0.00 |
| Div yield | 0.00% |

As of Oct 30, 2026

## Insider trading

[AngioDynamics, Inc. (ANGO) insider trading](https://massive.com/quote/ango/insider-trading.md): open-market Form 4 buys and sells by AngioDynamics, Inc. insiders over the last 12 months.

## 8-K filings

Material corporate events AngioDynamics, Inc. has disclosed to the SEC on Form 8-K.

- Oct 8, 2026 · Ceo appointment
  “On October 2, 2026, the Board of Directors of the Company appointed Eric Honroth to serve as President and Chief Executive Officer of the Company, effective as of November 2, 2026.”
- Oct 8, 2026 · Investor presentation
  “Presentation slides discussing AngioDynamics and its fiscal first quarter ended August 31, 2026 are furnished herewith as Exhibit 99.2.”
- Jul 14, 2026 · Investor presentation
  “Presentation slides discussing AngioDynamics and its fiscal fourth quarter and full year ended May 31, 2026 are furnished herewith as Exhibit 99.2.”
- Apr 23, 2026 · Material litigation
  “On April 23, 2026, AngioDynamics, Inc. filed a complaint commencing a patent infringement lawsuit in the United States District Court for the District of Delaware against Endovascular Engineering, Inc. The complaint alleges that E2's Hēlo Thrombectomy System unlawfully incorporates several features protected by registered patents held by the Company, including relating to the Company's proprietary self-expanding funnel technology and related features that improve the removal of thrombi and emboli from the body. The complaint seeks damages and equitable relief.”
- Apr 2, 2026 · Investor presentation
  “Presentation slides discussing AngioDynamics and its fiscal third quarter ended February 28, 2026 are furnished herewith as Exhibit 99.2.”

## Similar companies

Public companies in a similar business to AngioDynamics, Inc..

- [TMO](https://massive.com/quote/tmo.md) Thermo Fisher Scientific, Inc. (-1.72%)
- [WST](https://massive.com/quote/wst.md) West Pharmaceutical Services, Inc. (-0.97%)

Daily change in the latest session, 15-minute delayed.

## ANGO short interest

How heavily ANGO is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 1.5 |
| Short interest | 1.92M |
| Avg volume | 1.31M |

As of Oct 15, 2026 · reported to FINRA twice monthly.

## ANGO news

The latest news and headlines about AngioDynamics, Inc. (ANGO).

- [ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y](https://www.zacks.com/stock/news/3003837/ango-q1-earnings-beat-estimates-on-med-tech-growth-revenues-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-3003837) · Zacks Investment Research · Oct 9, 2026 · neutral sentiment
- [AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates](https://www.zacks.com/stock/news/3002448/angiodynamics-ango-reports-q1-loss-lags-revenue-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3002448) · Zacks Investment Research · Oct 8, 2026 · neutral sentiment
- [Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036](https://www.globenewswire.com/news-release/2026/01/16/3220178/28124/en/Atherectomy-Devices-Market-Size-by-Segments-Share-Regulatory-Reimbursement-Interventions-and-Forecast-to-2036.html) · GlobeNewswire Inc. · Jan 16, 2026 · positive sentiment
- [Why AngioDynamics Stock Is Sinking Today](https://www.fool.com/investing/2026/01/06/why-angiodynamics-stock-is-sinking-today/?source=iedfolrf0000001) · The Motley Fool · Jan 6, 2026 · negative sentiment
- [Why Did AngioDynamics Stock Pop Today?](https://www.fool.com/investing/2025/10/02/why-did-angiodynamics-stock-pop-today/?source=iedfolrf0000001) · The Motley Fool · Oct 2, 2025 · neutral sentiment

## About AngioDynamics, Inc.

AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Med Tech includes Auryon and Thrombectomy, while Med Device has Peripheral Products (Interventional Devices), Ports, and Microwave Ablation. Geographically operates in the USA and Other countries; maximum revenue from the USA.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 632 |
| Listed | May 27, 2004 |

[Company website](https://www.angiodynamics.com)

## FAQ

### What is the AngioDynamics, Inc. (ANGO) stock price today?

AngioDynamics, Inc. (ANGO) is trading at $11.99 (-2.91% on the day) as of 7:30:01 PM EDT on Oct 30, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is AngioDynamics, Inc.?

AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients…

### What is the short interest in ANGO?

As of Oct 15, 2026, ANGO has 1.92M shares short and 1.5 days to cover.

### What exchange is ANGO listed on?

AngioDynamics, Inc. (ANGO) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.

## Live data

Prices here are 15-minute delayed. For real-time ANGO quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=ANGO`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [AngioDynamics, Inc. (ANGO) insider trading](https://massive.com/quote/ango/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms